Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Journal of Personalized Medicine|May 28, 2022
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone TherapyMathias Neron, Arnaud Guille, Lucie Allegre, et al.
Molecular Cancer Therapeutics|May 9, 2022
Overcoming Resistance to Anti-Nectin-4 Antibody-Drug ConjugateOlivier Cabaud, Ludovic Berger, Emerence Crompot, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2009
Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in childrenLily S Subrata, Joelene Bizzintino, Emilie Mamessier, et al.
Journal of Translational Medicine|October 28, 2024
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapyFrançois Bertucci, Arnaud Guille, Florence Lerebours, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 10, 2022
Axin1 Protects Colon Carcinogenesis by an Immune-Mediated EffectRomain Sanson, Silvia Luna Lazzara, David Cune, et al.
Cancers|February 25, 2022
Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer PatientsAlexia Lopresti, Claire Acquaviva, Laurys Boudin, et al.
Journal of Translational Medicine|June 23, 2023
Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO networkElsa Nigon, Claudia Lefeuvre-Plesse, Alejandra Martinez, et al.
Hepatology (Baltimore, Md.)|August 6, 2019
Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular CarcinomaKohei Shigeta, Meenal Datta, Tai Hato, et al.
Cancer Research Communications|October 23, 2024
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing TumorsMarc Lopez, Emerence Crompot, Emmanuelle Josselin, et al.
Cancers|May 14, 2022
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical TrialEmilien Billon, Gwenaelle Gravis, Arnaud Guille, et al.
Pageof 9